Shanghai Micurx Pharmaceutical Co.,Ltd. Posted 125.1 Million Yuan Net Loss in First Half of 2023

Shanghai Micurx Pharmaceutical Co.,Ltd. (上海盟科药业股份有限公司) (688373.SH) reported a net loss of 125.1 million yuan in the first half of 2023, widening 16.1% year-on-year.

Meanwhile, the company posted 42.1 million yuan in revenue, up 106.6% year-on-year.

At the end of the reporting period, it had 1.4 billion yuan in total assets and 260.2 million yuan in total liabilities, with a liability-to-asset ratio of 18.9%.